Patent Assignment
Reel/Frame 024599/0071
Assignment of Assignor's Interest
Recorded: 2010-06-28
Pages: 4
Assignor
ENZON PHARMACEUTICALS, INC.
Executed: 2010-06-23
Assignee
DEFIANTE FARMACEUTICA, S.A.
RUA DOS FERREIROS 260, FUNCHAL-MADEIRA, 9000-082, PORTUGAL
Covered Property
(1)
Method of Treating CD4+ T Cell Lymphopenia in Immuno-Compromised Patients
Patent:
5,728,560 →
Application:
08/663,685 →
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 23, 1996
From: SHORR, ROBERT G.L.
To: ENZON, INC.
Reel/Frame 008145/0133 →
Assignment of Assignor's Interest
Sep 23, 1996
From: CLARK, MIKE A.
To: ENZON, INC.
Reel/Frame 008145/0135 →
Assignment of Assignor's Interest
Nov 25, 1996
From: GODDARD, DAVID H.
To: ENZON, INC.
Reel/Frame 008244/0222 →
Assignment of Assignor's Interest
Feb 7, 2012
From: DEFIANTE FARMACEUTICA, S.A.
To: SIGMA-TAU RARE DISEASES, S.A.
Reel/Frame 027662/0812 →
Merger
Apr 29, 2015
From: SIGMA TAU RARE DISEASES S.A.
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 035551/0219 →
Assignment of Assignor's Interest
Jul 1, 2015
From: SIGMA-TAU PHARMA LIMITED
To: SIGMA-TAU RARE DISEASE LTD
Reel/Frame 035948/0139 →
Change of Name
Dec 12, 2016
From: SIGMA-TAU RARE DISEASE LIMITED
To: LEADIANT BIOSCIENCES LIMITED
Reel/Frame 040716/0853 →